Cargando…
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
Breast cancer (BC) is the most common cancer in women and second only to lung cancer in terms of mortality. Among the three different BC subtypes, the oestrogen receptor positive represents nearly 70% of all cases and it is usually treated with anti-oestrogen drugs. However, the majority of hormone...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314865/ https://www.ncbi.nlm.nih.gov/pubmed/30622925 http://dx.doi.org/10.5306/wjco.v9.i8.172 |